Isabelle Manfroid

Dr. Isabelle Manfroid

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
DBDavid Bergemann
David Bergemann
LMLaura Massoz
Laura Massoz
JBJordane Bourdouxhe
Jordane Bourdouxhe
CPClaudio A. Carril Pardo
Claudio A. Carril Pardo
MVMarianne L. Voz
Marianne L. Voz
IMIsabelle Manfroid
Isabelle Manfroid

21 January 2022 in eLife
Verified
Journal Article
Open access
CPClaudio Andrés Carril Pardo
Claudio Andrés Carril Pardo
LMLaura Massoz
Laura Massoz
MDMarie A Dupont
Marie A Dupont
DBDavid Bergemann
David Bergemann
JBJordane Bourdouxhe
Jordane Bourdouxhe
IMIsabelle Manfroid
Isabelle Manfroid
Restoring damaged β-cells in diabetic patients by harnessing the plasticity of other pancreatic cells raises the questions of the efficiency of the process and of the functionality of the new Insulin-expressing cells. To overcome the weak regenerative capacity of mammals, we used regeneration-prone zebrafish to study β-cells arising following destruction. We show that most new insulin cells differ from the original β-cells as they coexpress Somatostatin and Insulin. These bihormonal cells are abundant, functional and able to normalize glycemia. Their formation in response to β-cell destruction is fast, efficient, and age-independent. Bihormonal cells are transcriptionally close to a subset of δ-cells that we identified in control islets and that are characterized by the expression of somatostatin 1.1 (sst1.1) and by genes essential for glucose-induced Insulin secretion in β-cells such as pdx1, slc2a2 and gck. We observed in vivo the conversion of monohormonal sst1.1-expressing cells to sst1.1+ ins + bihormonal cells following β-cell destruction. Our findings support the conclusion that sst1.1 δ-cells possess a pro-β identity enabling them to contribute to the neogenesis of Insulin-producing cells during regeneration. This work unveils that abundant and functional bihormonal cells benefit to diabetes recovery in zebrafish.

12 January 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
LMLaura Massoz
Laura Massoz
MDMarie Dupont
Marie Dupont
IMIsabelle Manfroid
Isabelle Manfroid
Regeneration is defined as the ability to regrow an organ or a tissue destroyed by degeneration or injury. Many human degenerative diseases and pathologies, currently incurable, could be cured if functional tissues or cells could be restored. Unfortunately, humans and more generally mammals have limited regenerative capabilities, capacities that are even further declining with age, contrary to simpler organisms. Initially thought to be lost during evolution, several studies have revealed that regenerative mechanisms are still present in mammals but are latent and thus they could be stimulated. To do so there is a pressing need to identify the fundamental mechanisms of regeneration in species able to efficiently regenerate. Thanks to its ability to regenerate most of its organs and tissues, the zebrafish has become a powerful model organism in regenerative biology and has recently engendered a number of studies attesting the validity of awakening the regenerative potential in mammals. In this review we highlight studies, particularly in the liver, pancreas, retina, heart, brain and spinal cord, which have identified conserved regenerative molecular events that proved to be beneficial to restore murine and even human cells and which helped clarify the real clinical translation potential of zebrafish research to mammals.

14 March 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ARAnne Sophie Reuter
Anne Sophie Reuter
DSDavid Stern
David Stern
ABAlice Bernard
Alice Bernard
CGChiara Goossens
Chiara Goossens
ALArnaud Lavergne
Arnaud Lavergne
MVMarianne Voz
Marianne Voz
ARP/ASCL transcription factors are key determinants of cell fate specification in a wide variety of tissues, coordinating the acquisition of generic cell fates and of specific subtype identities. How these factors, recognizing highly similar DNA motifs, display specific activities, is not yet fully understood. To address this issue, we overexpressed different ARP/ASCL factors in zebrafish ascl1a-/- mutant embryos to determine which ones are able to rescue the intestinal secretory lineage. We found that Ascl1a/b, Atoh1a/b and Neurod1 factors are all able to trigger the first step of the secretory regulatory cascade but distinct secretory cells are induced by these factors. Indeed, Neurod1 rescues the enteroendocrine lineage while Ascl1a/b and Atoh1a/b rescue the goblet cells. Gain-of-function experiments with Ascl1a/Neurod1 chimeric proteins revealed that the functional divergence is encoded by a 19-aa ultra-conserved element (UCE), present in all Neurod members but absent in the other ARP/ASCL proteins. Importantly, inserting the UCE into the Ascl1a protein reverses the rescuing capacity of this Ascl1a chimeric protein that cannot rescue the goblet cells anymore but can efficiently rescue the enteroendocrine cells. This novel domain acts indeed as a goblet cell fate repressor that inhibits gfi1aa expression, known to be important for goblet cell differentiation. Deleting the UCE domain of the endogenous Neurod1 protein leads to an increase in the number of goblet cells concomitant with a reduction of the enteroendocrine cells, phenotype also observed in the neurod1 null mutant. This highlights the crucial function of the UCE domain for NeuroD1 activity in the intestine. As Gfi1 acts as a binary cell fate switch in several tissues where Neurod1 is also expressed, we can envision a similar role of the UCE in other tissues, allowing Neurod1 to repress Gfi1 to influence the balance between cell fates.

3 May 2021 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SMStephanie Moortgat
Stephanie Moortgat
IMIsabelle Manfroid
Isabelle Manfroid
HPHélène Pendeville
Hélène Pendeville
SFStephen Freeman
Stephen Freeman
JBJordane Bourdouxhe
Jordane Bourdouxhe
IMIsabelle Maystadt
Isabelle Maystadt

17 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
CSCindy Streiff
Cindy Streiff
Bo HeBo He
Bo He
LMLéa Morvan
Léa Morvan
HZHaiyan Zhang
Haiyan Zhang
Natacha DelrezNatacha Delrez
Natacha Delrez
AVAlain Vanderplasschen
Alain Vanderplasschen
The zebrafish (Danio rerio) represents an increasingly important model organism in virology. We evaluated its utility in the study of economically important viruses from the genus Cyprinivirus (anguillid herpesvirus 1, cyprinid herpesvirus 2 and cyprinid herpesvirus 3 (CyHV-3)). This revealed that zebrafish larvae were not susceptible to these viruses after immersion in contaminated water, but that infections could be established using artificial infection models in vitro (zebrafish cell lines) and in vivo (microinjection of larvae). However, infections were transient, with rapid viral clearance associated with apoptosis-like death of infected cells. Transcriptomic analysis of CyHV-3-infected larvae revealed upregulation of interferon-stimulated genes, in particular those encoding nucleic acid sensors, mediators of programmed cell death and related genes. It was notable that uncharacterized non-coding RNA genes and retrotransposons were also among those most upregulated. CRISPR/Cas9 knockout of the zebrafish gene encoding protein kinase R (PKR) and a related gene encoding a protein kinase containing Z-DNA binding domains (PKZ) had no impact on CyHV-3 clearance in larvae. Our study strongly supports the importance of innate immunity-virus interactions in the adaptation of cypriniviruses to their natural hosts. It also highlights the potential of the CyHV-3-zebrafish model, versus the CyHV-3-carp model, for study of these interactions.